Summary
The clearest overlap between Selank and Thymosin Beta-4 is that both converge around Signaling modulator. Their typical research and application settings separate fairly clearly: Selank is more often discussed in the realm of Neurology and brain health and Immunology and inflammation, whereas Thymosin Beta-4 is more often associated with the realm of Musculoskeletal health, Cardiovascular health, and Dermatology and aesthetics. Both appear to work through Signaling modulator, but the functional emphasis still separates, with Selank leaning toward Anxiolytic and sleep modulation and Immune regulation and Thymosin Beta-4 leaning toward Tissue repair and healing, Angiogenesis modulation, and Anti-inflammatory. Selank has a more synthetic analog origin, while Thymosin Beta-4 is closer to natural endogenous background with Selank approved for Research use only and Thymosin Beta-4 in Clinical phase 2. Thymosin Beta-4 incorporates acetylation features that are not part of Selank, while their sequence patterns also diverge, with Selank showing proline-rich features and Thymosin Beta-4 showing protein-mimetic sequence features.